BET inhibitors in mCRPC

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

BET inhibitors in mCRPC

posted on Oct 20, 2017 01:41PM

BET inhibitors in metastatic prostate cancer: Therapeutic implications and rational drug combinations

https://www.ncbi.nlm.nih.gov/pubmed/29032717

Just accepted last Friday and published online on Monday 10/16

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply